D. Schiff

发表

Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT-737, through Regulating Mcl-1

Zhaohui Feng, Hao Wu, B. Haffty, 2014, Radiation research.

Disruption of GRM1‐mediated signalling using riluzole results in DNA damage in melanoma cells

Jairo L. Sierra, B. Wall, Suzie Chen, 2014, Pigment cell & melanoma research.

The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo

S. Danish, Suzie Chen, B. Haffty, 2019, Oncotarget.

Acyclovir Improves the Efficacy of Chemoradiation in Nasopharyngeal Cancer Containing the Epstein Barr Virus Genome

B. Haffty, A. Zloza, S. Jhawar, 2020, bioRxiv.

Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation.

V. Karantza, Hao Wu, B. Haffty, 2014, World journal of gastrointestinal oncology.

Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy

Sharad Goyal, Hao Wu, Bruce G. Haffty, 2011, Breast Cancer Research and Treatment.

Low p53 binding protein 1 (53BP1) expression is associated with increased local recurrence in breast cancer patients treated with breast-conserving surgery and radiotherapy.

S. Ganesan, Qifeng Yang, Hao Wu, 2012, International journal of radiation oncology, biology, physics.

Riluzole Enhances Ionizing Radiation–Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo

B. Wall, Suzie Chen, James S Goydos, 2011, Clinical Cancer Research.

Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT).

S. Ganesan, Qifeng Yang, B. Haffty, 2009, International journal of radiation oncology, biology, physics.

VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells

B. Haffty, S. Bunting, Atif J. Khan, 2018, Oncotarget.

Is Ki-67 expression prognostic for local relapse in early-stage breast cancer patients treated with breast conservation therapy (BCT)?

M. Harigopal, Qifeng Yang, Hao Wu, 2013, International journal of radiation oncology, biology, physics.

Clinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapy.

Qifeng Yang, B. Haffty, S. Goyal, 2010, International journal of radiation oncology, biology, physics.

CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.

A. Jetzt, Y. Ron, M. Singh, 1998, Clinical immunology and immunopathology.

Low p53 binding protein 1 (53BP1) expression is associated with increased local recurrence in breast cancer patients treated with breast-conserving surgery and radiotherapy.

S. Ganesan, Qifeng Yang, Hao Wu, 2012, International journal of radiation oncology, biology, physics.

Evaluation of Diabetic Patients with Breast Cancer Treated with Metformin during Adjuvant Radiotherapy

Sinae Kim, Hao Wu, B. Haffty, 2013, International journal of breast cancer.

Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer

T. Kuzel, N. LeBoeuf, B. Haffty, 2023, Journal for ImmunoTherapy of Cancer.